Skip to content
OpenCapital
Get started

Alignment Healthcare ALHC Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%—

Returns & leverage

See full
Return on equity12.6%+6.8pp
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Alignment Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Alignment Healthcare's share based compensation arrangement by share based payment award options vested and expected to vest exercisable aggregate intrinsic value?
Alignment Healthcare (ALHC) reported share based compensation arrangement by share based payment award options vested and expected to vest exercisable aggregate intrinsic value of $6.39M in Q1 2026.
How has Alignment Healthcare's share based compensation arrangement by share based payment award options vested and expected to vest exercisable aggregate intrinsic value changed year-over-year?
Alignment Healthcare's share based compensation arrangement by share based payment award options vested and expected to vest exercisable aggregate intrinsic value decreased by 44.7% year-over-year, from $11.55M to $6.39M.